Spyre Therapeutics Inc. (SYRE) earnings · $7.60B cap
These earnings events as JSON? API free 100/daySpyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
This SYRE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
When the next SYRE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for SYRE. We will not invent a beat or miss.
Not investment advice. Full SYRE research stays on the stock page; the tape stays on the quote page.
SYRE earnings FAQ
What is SYRE's latest net income?
Latest cached Spyre Therapeutics Inc. (SYRE) net income was -$155.2M. Statements: https://lician.com/financials/syre
What period does the latest SYRE earnings print cover?
The latest cached Spyre Therapeutics Inc. (SYRE) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are SYRE earnings listed?
Cached earnings facts for Spyre Therapeutics Inc. (SYRE) are listed at https://lician.com/earnings/syre. Statements: https://lician.com/financials/syre
Not investment advice.